Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
125770223	12577022	3	F	201606	20160825	20160720	20160902	EXP		DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-055638	BRISTOL MYERS SQUIBB		23.58	YR		F	Y	0.00000		20160902		MD	DE	DE

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
125770223	12577022	1	PS	REYATAZ	ATAZANAVIR SULFATE	1	Oral	300 MG, QD	21567	300	MG	CAPSULE, HARD	QD
125770223	12577022	2	SS	NORVIR	RITONAVIR	1	Oral	100 MG, UNK	0	100	MG
125770223	12577022	3	SS	TRUVADA	EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE	1	Oral	1 DF, UNK	0	1	DF

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
125770223	12577022	1	HIV infection
125770223	12577022	2	HIV infection
125770223	12577022	3	HIV infection

Outcome of event

Event ID	CASEID	OUTC COD
125770223	12577022	HO
125770223	12577022	OT

Reactions reported

Event ID	CASEID	PT
125770223	12577022	Abortion induced
125770223	12577022	Cervicectomy
125770223	12577022	Ectopic pregnancy
125770223	12577022	Haemorrhagic anaemia
125770223	12577022	Maternal exposure during pregnancy
125770223	12577022	Placenta accreta
125770223	12577022	Placenta praevia
125770223	12577022	Transfusion
125770223	12577022	Vaginal haemorrhage

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT
125770223	12577022	1	201402
125770223	12577022	2	201402
125770223	12577022	3	201402